Apr 11 2011
After timely breaking news this week about a study showing that estrogen lowers breast cancer risk in women, The American Academy of Anti-Aging Medicine (A4M, http://www.worldhealth.net) could have almost started its 19th Annual Conference here today saying "I told you so."
Long on the cutting-edge of medicine, the A4M has long held that estrogen helps prevent heart attacks and breast cancer.
According to Pamela Smith, MD, MPH, an expert in the field of hormone replacement therapy and author of "What You Must Know About Women's Hormones," the study conducted by Andrea LaCroix, an epidemiologist at Fred Hutchinson Cancer Center in Seattle, came as "no surprise."
"We at the A4M have always taught that estrogen (estradiol) replacement in estrogen deficient women helps prevent heart attacks and breast cancer and that conclusions drawn from the Women's Health Initiative study years ago were misleading. That study involved the synthetic progesterone called 'progestin,' which medical trials have shown may increase breast cancer risk, not the natural form of progesterone which medical trials have shown may decrease breast cancer risk."
Dr. Pamela Smith is teaching a module on Clinical Aspects of Hormone Replacement for Men and Women at the A4M Congress that runs through April 9 at the Marriott World Center Resort in Orlando. Nearly 2,000 doctors are attending The World Congress on Anti-Aging and Aesthetic Medicine.
A4M is a leader in medical conference education attracting thousands of physicians and medical practitioners from throughout the world.
Also today the Congress will cover such topics as Women's Health, A Metabolic Approach to Endocrinology, A Practical Application of Treating Adult Hormone Deficiency, Aesthetic Medicine and other Advance in Anti-Aging Medicine.
SOURCE American Academy of Anti-Aging Medicine
Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance